Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 5 | 2021 | 254 | 0.490 |
Why?
|
| Magnetite Nanoparticles | 3 | 2021 | 28 | 0.370 |
Why?
|
| Streptavidin | 2 | 2021 | 10 | 0.260 |
Why?
|
| Nucleocapsid Proteins | 1 | 2021 | 9 | 0.220 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 20 | 0.220 |
Why?
|
| Spectrum Analysis | 1 | 2021 | 82 | 0.210 |
Why?
|
| Ferric Compounds | 3 | 2017 | 45 | 0.200 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 236 | 0.200 |
Why?
|
| Biological Assay | 1 | 2021 | 88 | 0.200 |
Why?
|
| Smartphone | 1 | 2021 | 69 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 2220 | 0.190 |
Why?
|
| Transferrin | 1 | 2020 | 94 | 0.190 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2020 | 114 | 0.180 |
Why?
|
| Folic Acid | 1 | 2018 | 121 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 170 | 0.160 |
Why?
|
| Prostatic Neoplasms | 2 | 2013 | 778 | 0.150 |
Why?
|
| Metal Nanoparticles | 1 | 2017 | 88 | 0.150 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2015 | 14 | 0.150 |
Why?
|
| Cell Line, Tumor | 6 | 2020 | 1848 | 0.140 |
Why?
|
| Photochemotherapy | 1 | 2014 | 59 | 0.130 |
Why?
|
| Drug Carriers | 1 | 2014 | 90 | 0.130 |
Why?
|
| Genistein | 1 | 2013 | 26 | 0.130 |
Why?
|
| Polyethylene Glycols | 2 | 2015 | 149 | 0.120 |
Why?
|
| Taxoids | 1 | 2013 | 41 | 0.120 |
Why?
|
| Contrast Media | 1 | 2017 | 594 | 0.120 |
Why?
|
| Nanocapsules | 1 | 2013 | 10 | 0.120 |
Why?
|
| Particle Size | 3 | 2021 | 201 | 0.120 |
Why?
|
| Deoxycytidine | 1 | 2013 | 83 | 0.120 |
Why?
|
| Prostate | 1 | 2013 | 116 | 0.120 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 95 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 108 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 306 | 0.110 |
Why?
|
| Biofouling | 1 | 2010 | 14 | 0.100 |
Why?
|
| Methacrylates | 1 | 2010 | 31 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 307 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 467 | 0.100 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 54 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 332 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 624 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1173 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 561 | 0.090 |
Why?
|
| Mice | 6 | 2020 | 8453 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 756 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 532 | 0.080 |
Why?
|
| Animals | 7 | 2020 | 20811 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1070 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2013 | 294 | 0.060 |
Why?
|
| Hydrodynamics | 1 | 2021 | 15 | 0.050 |
Why?
|
| Magnetic Phenomena | 1 | 2021 | 12 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2021 | 218 | 0.050 |
Why?
|
| Theranostic Nanomedicine | 1 | 2020 | 6 | 0.050 |
Why?
|
| Influenza, Human | 1 | 2021 | 79 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2020 | 27 | 0.050 |
Why?
|
| Receptors, Transferrin | 1 | 2020 | 18 | 0.050 |
Why?
|
| Surface Properties | 1 | 2021 | 363 | 0.050 |
Why?
|
| Molecular Imaging | 1 | 2020 | 45 | 0.050 |
Why?
|
| Optical Imaging | 1 | 2020 | 46 | 0.050 |
Why?
|
| Ligands | 1 | 2020 | 317 | 0.040 |
Why?
|
| Humans | 8 | 2021 | 68502 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2018 | 28 | 0.040 |
Why?
|
| Cell Count | 1 | 2018 | 248 | 0.040 |
Why?
|
| Permeability | 1 | 2017 | 131 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 267 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2015 | 76 | 0.040 |
Why?
|
| Spleen | 1 | 2015 | 301 | 0.030 |
Why?
|
| Organosilicon Compounds | 1 | 2014 | 5 | 0.030 |
Why?
|
| Peptidomimetics | 1 | 2014 | 7 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 2014 | 48 | 0.030 |
Why?
|
| Female | 4 | 2020 | 37990 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 130 | 0.030 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2013 | 19 | 0.030 |
Why?
|
| Indoles | 1 | 2014 | 145 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 111 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2013 | 26 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 235 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2012 | 191 | 0.030 |
Why?
|
| Proteolysis | 1 | 2012 | 97 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2013 | 109 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 304 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 135 | 0.030 |
Why?
|
| Transfection | 1 | 2012 | 782 | 0.030 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2010 | 8 | 0.030 |
Why?
|
| Quantum Dots | 1 | 2010 | 29 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 144 | 0.020 |
Why?
|
| Culture Media | 1 | 2010 | 155 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 112 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2010 | 282 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1118 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 630 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 328 | 0.020 |
Why?
|
| Iron | 1 | 2010 | 197 | 0.020 |
Why?
|
| Male | 3 | 2015 | 37252 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 4650 | 0.020 |
Why?
|
| Macrophages | 1 | 2010 | 646 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1640 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 2684 | 0.010 |
Why?
|